Prescient Therapeutics (PTX.AX) Earnings Analysis
Prescient Therapeutics (PTX.AX) next reports earnings on 2026-08-20. Trailing P/E -9.31.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PTX.AX next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
PTX.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-04 | -0.00605 AUD | n/a | n/a | n/a |
| 2025-02-21 | -0.00304 AUD | n/a | n/a | n/a |
| 2024-08-26 | -0.00574 AUD | n/a | n/a | n/a |
PTX.AX valuation and analyst view
| Trailing P/E | -9.31 |
|---|---|
| Trailing EPS | -0.00883 AUD |
| Price / book | 5.56 |
| Dividend yield | 0.00% |
| Market cap | 0.08B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Prescient Therapeutics (PTX.AX)'s next earnings date?
Prescient Therapeutics is next scheduled to report on 2026-08-20.
Did PTX.AX beat earnings last quarter?
Consensus estimate data was not available for PTX.AX's 2025-08-04 report.
What is PTX.AX's current P/E ratio and EPS?
PTX.AX trades at a trailing P/E of -9.31 on trailing EPS of -0.008833930207786162 AUD.
What do analysts rate PTX.AX?
PTX.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.